Presumably, if a tumor expresses ERCC1, it will be able to repair the destruction caused by platinum chemotherapy while sustaining cellular proliferation, and therefore the effect of platins will be marginalized via ERCC1 expression. This evidence concerns the gene ERCC1 and neoplasm.